Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.81 is 14% below its 5-year average of 0.94, near the low end of its 5-year range (0.32–4.09).
As of the fiscal period ended Tuesday, June 30, 2026. 47.15% above its 12-month average of 0.55.
Reported quarterly current ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 0.81.
CURRENT RATIO
0.81
CURRENT RATIO AVG TTM
0.55
CURRENT RATIO AVG 3Y
0.66
CURRENT RATIO AVG 5Y
0.94
CURRENT RATIO AVG 10Y
0.71
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+47.15%
CURRENT VS 3Y AVG
+22.98%
CURRENT VS 5Y AVG
-14.12%
CURRENT VS 10Y AVG
+13.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-78.51%
vs the sector median at left
Outlook Therapeutics, Inc.
Market Cap
$106.96M
Current Ratio
0.81
TTM Avg
0.55
3Y Avg
0.66
5Y Avg
0.94
Market Cap
$106.98M
Current Ratio
0.96
TTM Avg
1.08
3Y Avg
1.26
5Y Avg
1.56
Market Cap
$107.09M
Current Ratio
5.71
TTM Avg
10.50
3Y Avg
6.63
5Y Avg
5.88
Market Cap
$107.17M
Current Ratio
5.68
TTM Avg
5.13
3Y Avg
4.85
5Y Avg
5.20
Market Cap
$109.14M
Current Ratio
2.00
TTM Avg
1.45
3Y Avg
1.62
5Y Avg
1.71
Market Cap
$104.68M
Current Ratio
13.53
TTM Avg
12.93
3Y Avg
9.36
5Y Avg
9.36
Market Cap
$104.26M
Current Ratio
1.86
TTM Avg
1.97
3Y Avg
2.28
5Y Avg
2.24
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | $106.96M | 0.81 | 0.55 | 0.66 | 0.94 |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | 0.96 | 1.08 | 1.26 | 1.56 |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | 3.25 | 3.06 | 4.28 | 3.23 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.09M | 5.71 | 10.50 | 6.63 | 5.88 |
| Apyx Medical Corporation (APYX)vs › | $107.17M | 5.68 | 5.13 | 4.85 | 5.20 |
| Immunic, Inc. (IMUX)vs › | $106.52M | 5.05 | 1.26 | 3.56 | 6.57 |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $109.14M | 2.00 | 1.45 | 1.62 | 1.71 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | 13.53 | 12.93 | 9.36 | 9.36 |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | 1.86 | 1.97 | 2.28 | 2.24 |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $110.30M | 12.63 | 12.83 | 15.22 | 15.22 |
Current Ratio
0.81
Quick Ratio
0.63
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.81 |
| 2026-03-31 | 0.54 |
| 2025-12-31 | 0.35 |
| 2025-09-30 | 0.38 |
| 2025-06-30 | 0.67 |
| 2025-03-31 | 0.72 |
| 2024-12-31 | 0.32 |
| 2024-09-30 | 0.64 |
| 2024-06-30 | 1.07 |
| 2024-03-31 | 1.07 |
| 2023-12-31 | 0.44 |
| 2023-09-30 | 0.66 |
| 2023-06-30 | 0.86 |
| 2023-03-31 | 1.22 |
| 2022-12-31 | 4.09 |
| 2022-09-30 | 1.39 |
| 2022-06-30 | 2.04 |
| 2022-03-31 | 2.12 |
| 2021-12-31 | 3.88 |
| 2021-09-30 | 3.19 |
| 2021-06-30 | 1.62 |
| 2021-03-31 | 1.83 |
| 2020-12-31 | 0.91 |
| 2020-09-30 | 1.13 |
| 2020-06-30 | 1.53 |
| 2020-03-31 | 0.40 |
| 2019-12-31 | 0.33 |
| 2019-09-30 | 0.67 |
| 2019-06-30 | 0.81 |
| 2019-03-31 | 0.08 |
| 2018-12-31 | 0.08 |
| 2018-09-30 | 0.10 |
| 2018-06-30 | 0.41 |
| 2018-03-31 | 0.22 |
| 2017-12-31 | 0.49 |
| 2017-09-30 | 0.14 |
| 2017-06-30 | 0.03 |
| 2017-03-31 | 0.02 |
| 2016-12-31 | 0.10 |
| 2016-09-30 | 0.28 |
| 2016-06-30 | 0.65 |
| 2016-03-31 | 0.11 |
| 2015-12-31 | 0.37 |
| 2015-09-30 | 0.16 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 0.00 |
